Related Experiment Video

Updated: Jun 16, 2026

Quantitative Analyses of all Influenza Type A Viral Hemagglutinins and Neuraminidases using Universal Antibodies in Simple Slot Blot Assays
13:12

Quantitative Analyses of all Influenza Type A Viral Hemagglutinins and Neuraminidases using Universal Antibodies in Simple Slot Blot Assays

Published on: April 4, 2011

A lipopeptide based on the M2 and HA proteins of influenza A viruses induces protective antibody

David Pejoski1, Weiguang Zeng, Steven Rockman

  • 1Department of Microbiology and Immunology, The University of Melbourne, Parkville, Victoria, Australia.

Immunology and Cell Biology
|February 24, 2010
PubMed

Insights

A novel lipopeptide vaccine candidate incorporating a conserved influenza A M2e peptide fragment elicits potent antibodies. These antibodies neutralize diverse influenza A virus subtypes and reduce viral load in mice.

Area of Science:

  • Virology
  • Immunology
  • Vaccine Development

Background:

  • The M2 ectodomain (M2e) of influenza A virus is a conserved target for universal influenza vaccines.
  • Developing effective M2e-based vaccines requires optimal antigen presentation and immune stimulation.

Purpose of the Study:

  • To evaluate a synthetic lipopeptide vaccine candidate containing a truncated M2e sequence for its immunogenicity and protective efficacy against influenza A virus.
  • To assess the breadth of the antibody response against different influenza A virus subtypes.

Main Methods:

  • Incorporation of a 15-amino acid M2e sequence into a lipopeptide construct with a T-helper epitope and a lipid moiety (Pam2Cys).
  • Immunization of mice with the lipopeptide vaccine candidate.
  • Measurement of M2e-specific antibody titers and avidity.
  • Assessment of antibody binding to influenza A virus-infected cells.
  • Evaluation of vaccine efficacy in reducing viral load after challenge with live influenza A virus.

Main Results:

  • The lipopeptide vaccine candidate induced a strong M2e-specific antibody response.
  • Antibodies recognized M2 protein from various influenza A virus subtypes.
  • Antibody titers were comparable to those induced by full-length M2e in Freund's adjuvant.
  • The vaccine significantly reduced viral load in mouse airways post-infection.

Conclusions:

  • A truncated M2e sequence in a lipopeptide format is a promising strategy for developing a universal influenza A vaccine.
  • The vaccine candidate elicits broadly reactive antibodies with protective capacity.
  • This approach offers a viable alternative to traditional influenza vaccines.

More Related Videos

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies07:55

Generation of Escape Variants of Neutralizing Influenza Virus Monoclonal Antibodies

Published on: August 29, 2017

A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies04:47

A Method to Assess Fc-mediated Effector Functions Induced by Influenza Hemagglutinin Specific Antibodies

Published on: February 23, 2018

Related Concept Videos

Leaky Scanning02:28

Leaky Scanning

During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA.  Marilyn Kozak discovered that the sequence RCCAUGG (where R stands for...
Influenza01:27

Influenza

Influenza is an acute, highly communicable viral disease that affects the respiratory tract and is responsible for seasonal epidemics worldwide. Influenza A is the most prevalent type associated with widespread outbreaks and is subtyped based on two surface glycoproteins: hemagglutinin (H) and neuraminidase (N), as in H1N1. These glycoproteins are essential for viral infectivity, transmission, and immune recognition. Transmission occurs primarily through respiratory droplets and contaminated...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Inhibitors Of Virion Release01:25

Inhibitors Of Virion Release

Viral replication and dissemination rely on efficient mechanisms for host cell entry, genome replication, assembly, and release. Influenza viruses, such as types A and B, are negative-sense single-stranded RNA viruses with a segmented genome, that depend on two critical surface glycoproteins to carry out these processes: hemagglutinin (HA) and neuraminidase (NA). HA initiates infection by binding to sialic acid residues on the surface of host epithelial cells, facilitating receptor-mediated...
Antigens Involved in Adaptive Immunity01:26

Antigens Involved in Adaptive Immunity

An antigen is any substance the immune system identifies as foreign and potentially harmful to the body, prompting an immune response. Antigens have two functional properties: immunogenicity and reactivity. Immunogenicity is the ability of an antigen to stimulate a specific immune response. At the same time, reactivity describes the antigen's ability to react with the cells and antibodies produced in response to it.
Complete Antigens
Complete antigens possess both immunogenicity and reactivity.